Latest & greatest articles for furosemide

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on furosemide or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on furosemide and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for furosemide

21. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.

Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants. BACKGROUND: Inhibition of prostaglandin synthesis mediates closure of the ductus arteriosus and renal side effects after indomethacin administration. Because furosemide increases prostaglandin production, it could potentially help prevent indomethacin-related toxicity but also decrease ductal response to indomethacin. OBJECTIVES: The primary objectives of this review were to assess (1) whether furosemide (...) affects the incidence of failure of ductal closure after indomethacin and that of indomethacin-related toxicity and (2) the effect of furosemide on mid-term and long-term outcome. The secondary objective was to determine whether the effect of furosemide on renal function and water balance depends on prior extracellular volume (assessed by blood urea nitrogen [BUN]/creatinine ratio). SEARCH STRATEGY: We searched electronic databases (Medline, Embase and Cochrane) and selected abstract books, without

Cochrane2000

22. Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint

Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint Spannheimer A, Goertz A, Dreckmann-Behrendt B Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of loop diuretics for the treatment of patients suffering from congestive heart failure (CHF). Two loop diuretics were compared, furosemide and torasemide. Type of intervention Treatment. Economic study type Cost-effectiveness analysis

NHS Economic Evaluation Database.1998

23. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group.

International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group. 9708751 1998 08 27 1998 08 27 2015 06 16 0140-6736 352 9126 1998 Aug 08 Lancet (London, England) Lancet International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group. 433-40 Furosemide and acetazolamide are widely used (...) intraventricular haemorrhage, were randomly assigned standard therapy alone or standard therapy plus treatment with acetazolamide (100 mg/kg daily) and furosemide (1 mg/kg daily). A minimisation algorithm ensured balance between groups with respect to both referral centre and the presence of a cerebral parenchymal lesion on cerebral ultrasonography at enrolment. The trial was stopped in September, 1996, because the data showed a clear advantage with standard therapy. We report outcomes for 151 infants whose

Lancet1998

24. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. 9482291 1998 03 18 1998 03 18 2015 06 16 0140-6736 351 9100 1998 Feb 07 Lancet (London, England) Lancet Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. 389-93 Nitrates and furosemide, commonly administered (...) in the treatment of pulmonary oedema, have not been compared in a prospective clinical trial. We compared the efficacy and safety of these drugs in a randomised trial of patients with severe pulmonary oedema and oxygen saturation below 90%. Patients presenting to mobile emergency units with signs of congestive heart failure were treated with oxygen 10 L/min, intravenous furosemide 40 mg, and morphine 3 mg bolus. 110 patients were randomly assigned either to group A, who received isosorbide dinitrate (3 mg

Lancet1998

25. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.

Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. 7969280 1994 11 28 1994 11 28 2017 02 14 0028-4793 331 21 1994 11 24 The New England journal of medicine N. Engl. J. Med. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. 1416-20 Injections of radiocontrast agents are a frequent cause of acute decreases in renal function, occurring most often in patients (...) with chronic renal insufficiency and diabetes mellitus. We prospectively studied 78 patients with chronic renal insufficiency (mean [+/- SD] serum creatinine concentration, 2.1 +/- 0.6 mg per deciliter [186 +/- 53 mumol per liter]) who underwent cardiac angiography. The patients were randomly assigned to receive 0.45 percent saline alone for 12 hours before and 12 hours after angiography, saline plus mannitol, or saline plus furosemide. The mannitol and furosemide were given just before angiography. Serum

NEJM1994

26. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients

Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club1992

27. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions.

Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. 2797066 1989 11 07 1989 11 07 2015 11 19 0028-4793 321 16 1989 Oct 19 The New England journal of medicine N. Engl. J. Med. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. 1069-73 The movement of ions and water across the membranes of bronchial cells is part of the control of the bronchial obstructive response to physical stimuli. In a double-blind (...) , randomized, crossover study, we compared the effect of an aerosol of the loop diuretic furosemide with that of a placebo on the early (within 60 minutes) and late (4 to 12 hours) asthmatic responses to a specific inhaled allergen. We studied 11 subjects with mild allergic asthma, who had both early and late asthmatic responses to a specific inhaled allergen in a preliminary challenge. After placebo administration, the maximal changes (mean +/- SE) from base line in the forced expiratory volume in one

NEJM1989

28. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome.

Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. 6828120 1983 04 15 1983 04 15 2013 11 21 0028-4793 308 13 1983 Mar 31 The New England journal of medicine N. Engl. J. Med. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. 743-8 Furosemide stimulates the renal synthesis of prostaglandin E2, a potent dilator of the ductus arteriosus. We administered this drug to 33 premature infants (...) with the respiratory-distress syndrome, to determine whether it increased the incidence of patent ductus arteriosus. Chlorothiazide, a diuretic that does not stimulate prostaglandin E synthesis, was used as the control drug in 33 other infants. During the study, the incidence of patent ductus arteriosus was significantly higher (P less than 0.02) in the furosemide group (18 of 33 infants) than in the chlorothiazide group (8 of 33). Eleven infants in the furosemide group and seven in the chlorothiazide group

NEJM1983

29. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.

Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension. 357764 1978 12 02 1978 12 02 2016 10 17 0098-7484 240 17 1978 Oct 20 JAMA JAMA Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension. 1863-6 In a double-blind crossover study, the effectiveness of furosemide, 40 mg twice daily, was compared with hydrochlorothiazide, 50 mg twice daily, in hypertensive patients. Both hydrochlorothiazide and furosemide significantly reduced blood (...) pressure (BP) during three months of therapy. However, the fall in BP was consistently greater with hydrochlorothiazide than with furosemide, although the difference was significant only with respect to systolic BP. The somewhat greater antihypertensive effectiveness of hydrochlorothiazide may be related to its longer action permitting a more continuous diuretic effect and, hence, maintenance of reduced extracellular fluid volume throughout the 24-hour period. Araoye M A MA Chang M Y MY Khatri I M IM Freis

JAMA1978